Conversion From Azathioprine to Mycophenolate Mofetil Followed by Calcineurin Inhibitor Minimization or Elimination in Patients With Chronic Allograft Dysfunction

Transplantation Proceedings

Volumn 38, Issue 9, 2006, Pages 2872-2878

  Garcia, R ^a   Pinheiro Machado, P G ^a   Felipe, C R ^a   Park, S I ^a   Silva, L A ^a   Franco, M F ^a   Tedesco Silva Jr , H ^a   Medina Pestana, J O ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TSUKUBAENOLIDE;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BACTERIAL INFECTION; BLOOD ANALYSIS; CAUCASIAN; CHEMICAL ANALYSIS; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DRUG DOSE REDUCTION; DRUG ELIMINATION; DRUG FATALITY; DRUG INDUCED CANCER; DRUG SUBSTITUTION; DRUG UTILIZATION; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; STEROID THERAPY; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VIRUS INFECTION;

ADULT; AZATHIOPRINE; CHRONIC DISEASE; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISONE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33750959909     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.10.001     Document Type: Article

References (20)

1. Siddiqi N., McBride M.A., and Hariharan S. Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis. Kidney Int 65 (2004) 1906
2. Kasiske B.L., Andany M.A., Hernandez D., et al. Comparing methods for monitoring serum creatinine to predict late renal allograft failure. Am J Kidney Dis 38 (2001) 1065
3. Kaplan B., Schold J., and Meier-Kriesche H.U. Poor predictive value of serum creatinine for renal allograft loss. Am J Transpl 3 (2003) 1560
4. Nankiveli B.J., Borrows R.J., Fung C.L., et al. The natural history of chronic allograft nephropathy. N Engl J Med 349 (2003) 2326
5. Gill J.S., Tonelli M., Mix S.H., et al. The changes in allograft function among long-term kidney transplant recipients. J Am Soc Nephrol 14 (2003) 1636
6. Gourishankar S., Hunsicker L.G., Jhangri G.S., et al. The stability of the glomerular filtration rate after renal transplantation is improving. J Am Soc Nephrol 14 (2003) 2387
7. Kasiske B.L., Chakkera H.A., Louis T.A., et al. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 11 (2000) 1910
8. Paul L.C. Chronic allograft nephropathy: An update. Kidney Int 56 (1999) 783
9. Regele H., Bohmig G.A., Habicht A., et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 13 (2002) 2371
10. Molina M.G., Seron D., and del Moral R.G. Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathy. A follow-up study by the Spanish Cooperative Study Group of Chronic Allograft Nephropathy. Transplantation 77 (2004) 215
11. Thervet E., Martinez F., and Legendre C. Benefit-risk assessment of ciclosporin withdrawal in renal transplant recipients. Drug Saf 27 (2004) 457
12. Dudley C., Pohanka E., Riad H., et al. Mycophenolate mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction: the "creeping creatinine" study. Transplantation 79 (2005) 466
13. Weir M.R., Ward M.T., Blahut S.A., et al. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy. Kidney Int 59 (2001) 1567
14. Suwelack B., Gerhardt U., and Hohage H. Withdrawal of cyclosporine or tacrolimus after addition of mycophenolate mofetil in patients with chronic allograft nephropathy. Am J Transplant 4 (2004) 655
15. Weir M.R., Blahut S., Drachenburg C., et al. Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant function. Am J Nephrol 24 (2004) 379
16. Morales J.M. Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation. Kidney Int 62 (2002) S81
17. Opelz G., Wujciak T., and Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int 53 (1998) 217
18. Danovitch G.M. How should the immunosuppressive regimen be managed in patients with established chronic allograft failure?. Kidney Int 61 (2002) S68
19. Meier-Kriesche H.U., Shaw L.M., Korecka M., et al. Pharmacokinetics of mycophenolic acid in renal insufficiency. Ther Drug Monit 22 (2000) 27
20. Shaw L.M., Holt D.W., Oellerich M., et al. Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion. Ther Drug Monit 23 (2000) 305